The Global Branded Generics Market valued at USD XX billion in 2020 and is expected to grow at CAGR of XX% over the forecast period.
Branded generic drugs are new formulations of the off patented drugs which can be sold either by the manufacturer of the patented drug or by the generic drug companies that build up brand equity for their generic versions of the medications. An example of branded generic medicine is Teva's version of sabril (viagabatrin), approved by the FDA last year. Branded generics differ from ‘commodity generics,’ pharmaceutical products, generally used as an alternative to innovator products after the patent expiry.
The major factors driving the market growth are growth in the number of expired and expiring patents for the branded drugs, simple marketing authorization procedures, entry of new players, changing medicine practices, greater profit margin. Population suffering from chronic diseases and disorders contribute to the market growth. High competition from branded drugs and commodity generic products can hinder market growth. Lack of penetration associated with the number of generic drugs can also restraint market growth.
Differentiation in the final product is expected to offer tremendous growth opportunities for the market players to differentiate in color, shape, taste, inactive ingredients, preservatives, and packaging. Offering low-cost branded generics to remain competitive in the market is the focus of the key players in the market, and this can be achieved by strategic sourcing of raw materials from emerging economies and partnering with suppliers.
Market Segmentation
Branded generics market is segmented based on the drug class, formulation, indication, by distribution channel, and region.
Branded Generics Market, by Drug Class
Based on drug class, the market is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid-lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, and others. The market is dominated by the anti-hypertensive segment as branded generics drugs are expected to gain growth in cardiovascular diseases.
Branded Generics Market, by Formulation
Based on formulation, the market is divided into oral, parenteral, topical, and others. Oral solid dose pharmaceutical formulation continues to be highly preferred among patients by value owing to the convenience factor of oral administration. The parenteral formulation segment can gather momentum in terms of preference among patients opting for branded generics medicines.
Branded Generics Market, by Indication
Based on indication, the market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, analgesics and anti-inflammatory, and others. Cardiovascular diseases (CVDs) and diabetes continue to account for more than 20% of total sales of branded generics in the global market. CNS Drugs segment is expected to grow during the forecast period due to the rapid growth patent expiry of several key antipsychotics and antidepressants manufacturers.
Branded Generics Market, by Distribution Channel
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. Hospital and retail drug stores are expected to stay prominent distribution channels for branded generics.
Branded Generics Market, by Region
Based on the region, the market has been segmented by North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. North America accounts for the largest market size for branded generics and is projected to lead the market during the forecast period. This is due to the increasing demand for cost-effective medicines in the region. Competition exists in Canada for the supply of generic drugs. Europe is the second-largest region for branded generics market, where patients cannot afford the expensive branded medicines. Due to increasing healthcare infrastructure and government funding, Asia-Pacific is projected to grow gradually during the forecast period and is expected to account for the largest market size globally.
Competitive Analysis
Global branded generics market is highly fragmented and the major players have used various strategies such as new product launches, joint ventures, expansions, acquisitions, agreements, partnerships, and others to increase their footprints in this market.
Mylan N.V, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Aspen Pharmacare Holding Ltd., Abbott Laboratories, and Valeant Pharmaceuticals International, Inc. are some of the key players of the branded generics market.
The report also includes the company profiles of key branded generics market along with their SWOT analysis and market strategies. In addition, the competitive landscapes provide a detailed description of each company including future capacities, key mergers and acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.
Key Developments in the bone replacement products market
- In 2019, Sandoz agreed to acquire Japanese business of Aspen Global to expand its presence in the third largest generics marketplace in the world
- In January 2019, Hetero announced the launch of generic version of “lapatinib” in India, which will be commercialized as “Hertab” by Hetero Healthcare Ltd.
What Does This Report Provide?
A detailed understanding of the global branded generics market from qualitative and quantitative perspectives during the forecast period. The report also provides the potential impact dynamic indicators on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.
Market Segmentation:
By Drug Class:
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-Hypertensive
- Lipid Lowering Drugs
- Anti-Depressants
- Anti-Psychotics
- Anti-Epileptics
- Others
By Formulation:
- Oral
- Parenteral
- Topical
- Others
By Indication:
- Oncology
- Cardiovascular Diseases
- Diabetes
- Neurology
- Gastrointestinal Diseases
- Dermatology Diseases
- Analgesics and Anti-inflammatory
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
By Region:
North America Branded Generics Market
- North America, by Country
- US
- Canada
- Mexico
- North America, by Drug Class
- North America, by Formulation
- North America, by Indication
- North America, by Distribution Channel
Europe Branded Generics Market
- Europe, by Country
- Germany
- Russia
- UK
- France
- Italy
- Spain
- The Netherlands
- Rest of Europe
- Europe, by Drug Class
- Europe, by Formulation
- Europe, by Indication
- Europe, by Distribution Channel
Asia Pacific Branded Generics Market
- Asia Pacific, by Country
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Asia Pacific, by Drug Class
- Asia Pacific, by Formulation
- Asia Pacific, by Indication
- Asia Pacific, by Distribution Channel
Middle East & Africa Branded Generics Market
- Middle East & Africa, by Country
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
- Middle East & Africa, by Drug Class
- Middle East & Africa, by Formulation
- Middle East & Africa, by Indication
- Middle East & Africa, by Distribution Channel
South America Branded Generics Market
- South America, by Country
- Brazil
- Argentina
- Colombia
- Rest of South America
- South America, by Drug Class
- South America, by Formulation
- South America, by Indication
- South America, by Distribution Channel
Reasons to Buy This Report:
- Provides niche insights for decision about every possible segment helping in strategic decision making process.
- Market size estimation of the branded generics market on a regional and global basis.
- A unique research design for market size estimation and forecast.
- Identification of major companies operating in the market with related developments
- Exhaustive scope to cover all the possible segments helping every stakeholder in the branded generics
Customization:
This study is customized to meet your specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
- Product Specific Competitive Analysis
For more information, contact: sales@quincemarketinsights.com